Network / Interactive Map / Entity profile

Kyron.bio

Kyron.bio

Description

At Kyron.bio, our mission is to unlock the superior efficacy of protein therapeutics by leveraging the power of glycan modifications.
Our novel engineering strategy precisely controls glycosylation patterns, opening a new era of antibody therapeutics. This has the power to deliver better therapies and transform patient outcomes.

Referent Contact

Emilia McLaughlin

emilia@kyron.bio

Kyron.bio

Address

6 rue Jean Calvin
75005 Paris, France

Contact

hello@kyron.bio

Description

At Kyron.bio, our mission is to unlock the superior efficacy of protein therapeutics by leveraging the power of glycan modifications.
Our novel engineering strategy precisely controls glycosylation patterns, opening a new era of antibody therapeutics. This has the power to deliver better therapies and transform patient outcomes.

Matchmaking

Connect with Kyron.bio

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways
Back to directory